MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • MDS Virtual Congress 2021

    The study of genetic factors in motor levodopa-induced complications development in Russian patients with Parkinson’s disease

    G. Akhmadeeva, I. Khidiyatova, I. Gilyazova, G. Tayupova, S. Umutbaev, A. Baitimerov, R. Magzhanov (Ufa, Russian Federation)

    Objective: The aim of our study is to search for genetic risk factors for the development of motor side effects of dopaminergic therapy, such as…
  • MDS Virtual Congress 2021

    SRY as a potential therapeutic target for men with Parkinson’s Disease

    V. Harley (Clayton, Australia)

    Objective: Develop a potential disease-modifying gene therapy for men with Parkinson’s Disease Background: A hallmark symptom of PD is the loss of midbrain dopamine (DA)…
  • MDS Virtual Congress 2021

    HYPERSEXUAL DISORDER IN GBA-ASSOCIATED PARKINSON’S DISEASE: CASE REPORT

    M. Montenegro, C. Malcher, V. Cardoso, A. Escudeiro, A. Silva, B. Santos-Lobato (Belém, Brazil)

    Objective: To describe a patient with PD and hypersexual disorder carrying a GBA variant. Background: Compulsive sexual behavior occurs in 4% of patients with Parkinson’s…
  • MDS Virtual Congress 2021

    Mutations in GBA and LRRK2 are not associated with increased inflammatory markers

    A. Thaler, N. Omer, N. Giladi, T. Gurevich, A. Bar Shira, O. Goldstein, M. Gana-Weisz, M. Kestenbaum, J. Shirvan, J. Cedarbaum, A. Orr-Urtreger, S. Shenhar-Tsarfaty, A. Mirelman (Tel-Aviv, Israel)

    Objective: To assess central and peripheral cytokines among Parkinson's disease (PD) patients with mutations in the LRRK2 and GBA genes as well as among non-manifesting…
  • MDS Virtual Congress 2021

    Molecular investigation of apparently healthy heterozygous Parkin mutation carriers

    M. Castelo, A. Zanon, V. Gilmozzi, C. Klein, P. Pramstaller, A. Hicks, I. Pichler (Bolzano, Italy)

    Objective: To investigate whether apparently healthy individuals carrying a heterozygous pathogenic Parkin (PRKN) mutation show molecular phenotypes of mitochondrial dysfunction. Background: Homozygous or compound-heterozygous mutations…
  • MDS Virtual Congress 2021

    CSF MicroRNA Analysis Reveals Angiogenesis And Autophagy Defects In Parkinson’s DiseasePatients

    C. Moussa, Y. Torres-Yaghi, F. Pagan (Washington, USA)

    Objective: We investigated the effects of discoidin domain receptor (DDR)-1 inhibition on CSF miRNAs in Parkinson’s disease patients. Background: MicroRNAs (miRNAs) are post-transcriptional regulators of…
  • MDS Virtual Congress 2021

    Motor cerebro-cerebellar networks breakdown among different subtypes of Parkinson’s disease

    S. Basaia, F. Agosta, A. Francia, C. Cividini, T. Stojkovic, I. Stankovic, R. de Micco, L. Albano, E. Sarasso, A. Gardoni, N. Piramide, V. Markovic, E. Stefanova, V. Kostic, M. Filippi (Milan, Italy)

    Objective: The aim of this study was to investigate functional alterations within motor circuits of the cerebro-cerebellar system in tremor-dominant (TD) and postural instability and…
  • MDS Virtual Congress 2021

    Compensatory functional mechanisms of response inhibition in Parkinson’s Disease with impulse control disorders

    T. Esteban-Peñalba, P. Paz-Alonso, I. Navalpotro-Gomez, M. Rodriguez-Oroz (Donostia, Spain)

    Objective: To investigate response inhibition in Parkinson’s disease (PD) patients with impulse control disorders. Specifically, the neural underpinnings of two aspects of inhibition: proactive inhibition…
  • MDS Virtual Congress 2021

    The evaluation of the swallow tail sign in patients with parkinsonism or gait disorders

    D. Kim, G. Tung, U. Akbar, J. Friedman (Providence, USA)

    Objective: The goal of the study is to evaluate the reliability of swallow tail sign which claimed to be specific for Parkinson's disease. Background: Swallow…
  • MDS Virtual Congress 2021

    Clinical and transcranial sonography characteristics in benign phenotype of Parkinson’s disease.

    A. Planas-Ballvé, N. Caballol, A. ávila (Barcelona, Spain)

    Objective: To investigate clinical and transcranial B-mode sonography (TCS) characteristics of benign phenotype of Parkinson’s disease (bPD). Background: Parkinson’s disease (PD) progression is heterogeneous. A…
  • « Previous Page
  • 1
  • …
  • 99
  • 100
  • 101
  • 102
  • 103
  • …
  • 132
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • Nilotinib for treating MSA: A preclinical proof of concept study
  • An atypical and interesting feature of Parkinson´s disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • An atypical and interesting feature of Parkinson´s disease
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley